According to the Zhitong Finance App, China Resources Pharmaceutical (03320) announced the results of Kunming Pharmaceutical Group for the first nine months of 2026. Total operating revenue was about 2,722 billion yuan, a year-on-year decrease of 42.7%; net loss was about 363 million yuan, a year-on-year profit and loss.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.